Niraarya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 1.00 M
as on 16-12-2024
- Company Age 6 Year, 15 Days
- Last Filing with ROC 31 Mar 2021
About Niraarya Life Sciences
The Corporate was formerly known as Tanira Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Raghuchaitanya Nayak, Yashasvini Nagarajurs, Nagaraja Nivedan, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100KA2018PTC119301
- Company No.
119301
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Niraarya Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghuchaitanya Nayak  | Director | 11-Dec-2018 | Current |
| Yashasvini Nagarajurs | Director | 03-Sep-2020 | Current |
| Nagaraja Nivedan | Director | 11-Dec-2018 | Current |
| Jeevanath Archana | Director | 03-Sep-2020 | Current |
Financial Performance of Niraarya Life Sciences.
Niraarya Life Sciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Niraarya Life Sciences?
In 2020, Niraarya Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Friendly Homes India Private LimitedActive 11 years 11 monthsRaghuchaitanya Nayak is a mutual person
_PRIVATE_LIMITED.webp)
Friendly Automotives (India) Private LimitedActive 14 years 6 daysRaghuchaitanya Nayak is a mutual person
Sri Dharmasthala Siri Gramodyoga SamstheActive 20 years 9 monthsNagaraja Nivedan is a mutual person
- Friendly Motors (India) Private LimitedActive 18 years 1 month
Raghuchaitanya Nayak is a mutual person
- Friendly Elements (India) Private LimitedActive 5 years 2 months
Raghuchaitanya Nayak and Yashasvini Nagarajurs are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Niraarya Life Sciences?
Unlock and access historical data on people associated with Niraarya Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Niraarya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niraarya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
